ID   DCOR_HUMAN              Reviewed;         461 AA.
AC   P11926; Q53TU3; Q6LDS9;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 2.
DT   12-APR-2017, entry version 188.
DE   RecName: Full=Ornithine decarboxylase;
DE            Short=ODC;
DE            EC=4.1.1.17 {ECO:0000269|PubMed:17407445};
GN   Name=ODC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3595418; DOI=10.1089/dna.1987.6.179;
RA   Hickok N.J., Seppaenen P.J., Gunsalus G.L., Jaenne O.A.;
RT   "Complete amino acid sequence of human ornithine decarboxylase deduced
RT   from complementary DNA.";
RL   DNA 6:179-187(1987).
RN   [2]
RP   SEQUENCE REVISION TO 415.
RA   Jaenne O.A.;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2693021; DOI=10.1089/dna.1.1989.8.623;
RA   Fitzgerald M.C., Flanagan M.A.;
RT   "Characterization and sequence analysis of the human ornithine
RT   decarboxylase gene.";
RL   DNA 8:623-634(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2587220; DOI=10.1093/nar/17.21.8855;
RA   van Steeg H., van Oostrom C.T.M., Martens J.W.M., van Kreyl C.F.,
RA   Schepens J., Wieringa B.;
RT   "Nucleotide sequence of the human ornithine decarboxylase gene.";
RL   Nucleic Acids Res. 17:8855-8856(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2227439; DOI=10.1016/0378-1119(90)90233-H;
RA   Hickok N.J., Wahlfors J., Crozat A., Halmekytoe M., Alhonen L.,
RA   Jaenne J., Jaenne O.A.;
RT   "Human ornithine decarboxylase-encoding loci: nucleotide sequence of
RT   the expressed gene and characterization of a pseudogene.";
RL   Gene 93:257-263(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2318872;
RA   Moshier J.A., Gilbert J.D., Skunca M., Dosescu J., Almodovar K.M.,
RA   Luk G.D.;
RT   "Isolation and expression of a human ornithine decarboxylase gene.";
RL   J. Biol. Chem. 265:4884-4892(1990).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1598217; DOI=10.1093/nar/20.10.2581;
RA   Moshier J.A., Osborne D.L., Skunca M., Dosescu J., Gilbert J.D.,
RA   Fitzgerald M.C., Polidori G., Wagner R.L., Friezner Degen S.J.,
RA   Luk G.D., Flanagan M.A.;
RT   "Multiple promoter elements govern expression of the human ornithine
RT   decarboxylase gene in colon carcinoma cells.";
RL   Nucleic Acids Res. 20:2581-2590(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8519686;
RA   Wright P.S., Cooper J.R., Cross-Doersen D.E., Miller J.A.,
RA   Chmielewski P.A., Wagner R.L., Streng K.A., Flanagan M.A.;
RT   "Regulation of ornithine decarboxylase mRNA levels in human breast
RT   cancer cells: pattern of expression and involvement of core enhancer
RT   promoter element.";
RL   Cell Growth Differ. 6:1097-1102(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Esophagus, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-22.
RX   PubMed=2317811;
RA   Hsieh J.T., Denning M.F., Heidel S.M., Verma A.K.;
RT   "Expression of human chromosome 2 ornithine decarboxylase gene in
RT   ornithine decarboxylase-deficient Chinese hamster ovary cells.";
RL   Cancer Res. 50:2239-2244(1990).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 112-461.
RX   PubMed=3308908; DOI=10.1002/jcp.1041320318;
RA   Kaczmarek L., Calabretta B., Ferrari S., de Riel J.K.;
RT   "Cell-cycle-dependent expression of human ornithine decarboxylase.";
RL   J. Cell. Physiol. 132:545-551(1987).
RN   [16]
RP   S-NITROSYLATION.
RX   PubMed=10462479; DOI=10.1006/bbrc.1999.1210;
RA   Bauer P.M., Fukuto J.M., Buga G.M., Pegg A.E., Ignarro L.J.;
RT   "Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation.";
RL   Biochem. Biophys. Res. Commun. 262:355-358(1999).
RN   [17]
RP   S-NITROSYLATION AT CYS-360, AND MUTAGENESIS OF CYS-360.
RX   PubMed=11461922; DOI=10.1074/jbc.M105219200;
RA   Bauer P.M., Buga G.M., Fukuto J.M., Pegg A.E., Ignarro L.J.;
RT   "Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of
RT   cysteine 360 in the active site of the enzyme.";
RL   J. Biol. Chem. 276:34458-34464(2001).
RN   [18]
RP   INDUCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells
RT   reveal differential cellular gene expression in response to
RT   enterovirus 71 infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [19]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=17900240; DOI=10.1042/BJ20071004;
RA   Kanerva K., Makitie L.T., Pelander A., Heiskala M., Andersson L.C.;
RT   "Human ornithine decarboxylase paralogue (ODCp) is an antizyme
RT   inhibitor but not an arginine decarboxylase.";
RL   Biochem. J. 409:187-192(2008).
RN   [20] {ECO:0000244|PDB:1D7K}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 7-427, AND SUBUNIT.
RX   PubMed=10623504; DOI=10.1006/jmbi.1999.3331;
RA   Almrud J.J., Oliveira M.A., Kern A.D., Grishin N.V., Phillips M.A.,
RA   Hackert M.L.;
RT   "Crystal structure of human ornithine decarboxylase at 2.1 A
RT   resolution: structural insights to antizyme binding.";
RL   J. Mol. Biol. 295:7-16(2000).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH COFACTOR AND
RP   SUBSTRATE ANALOGS, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=17407445; DOI=10.1042/BJ20070188;
RA   Dufe V.T., Ingner D., Heby O., Khomutov A.R., Persson L.,
RA   Al-Karadaghi S.;
RT   "A structural insight into the inhibition of human and Leishmania
RT   donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane.";
RL   Biochem. J. 405:261-268(2007).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.63 ANGSTROMS) OF 2-421 IN COMPLEX WITH
RP   COFACTOR AND OAZ1.
RX   PubMed=26305948; DOI=10.1073/pnas.1508187112;
RA   Wu H.Y., Chen S.F., Hsieh J.Y., Chou F., Wang Y.H., Lin W.T.,
RA   Lee P.Y., Yu Y.J., Lin L.Y., Lin T.S., Lin C.L., Liu G.Y., Tzeng S.R.,
RA   Hung H.C., Chan N.L.;
RT   "Structural basis of antizyme-mediated regulation of polyamine
RT   homeostasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:11229-11234(2015).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) IN COMPLEX WITH COFACTOR; OAZ1
RP   AND INHIBITOR.
RX   PubMed=26443277; DOI=10.1038/srep14738;
RA   Wu D., Kaan H.Y., Zheng X., Tang X., He Y., Vanessa Tan Q., Zhang N.,
RA   Song H.;
RT   "Structural basis of ornithine decarboxylase inactivation and
RT   accelerated degradation by polyamine sensor antizyme1.";
RL   Sci. Rep. 5:14738-14738(2015).
CC   -!- FUNCTION: Catalyzes the first and rate-limiting step of polyamine
CC       biosynthesis that converts ornithine into putrescine, which is the
CC       precursor for the polyamines, spermidine and spermine. Polyamines
CC       are essential for cell proliferation and are implicated in
CC       cellular processes, ranging from DNA replication to apoptosis.
CC       {ECO:0000269|PubMed:17900240}.
CC   -!- CATALYTIC ACTIVITY: L-ornithine = putrescine + CO(2).
CC       {ECO:0000269|PubMed:17407445}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:17407445,
CC         ECO:0000269|PubMed:26443277};
CC   -!- ENZYME REGULATION: Inhibited by S-nitrosylation (PubMed:10462479,
CC       PubMed:11461922). Inhibited by antizymes (AZs) OAZ1, OAZ2 and OAZ3
CC       in response to polyamine levels. AZs inhibit the assembly of the
CC       functional homodimer by binding to ODC monomers. Additionally,
CC       OAZ1 targets ODC monomers for ubiquitin-independent proteolytic
CC       destruction by the 26S proteasome (PubMed:17900240). Inhibited by
CC       1-amino-oxy-3-aminopropane (APA, an isosteric analog of
CC       putrescine) (PubMed:17407445). Irreversibly inhibited by alpha-
CC       difluoromethylornithine (DFMO) (PubMed:17407445).
CC       {ECO:0000269|PubMed:10462479, ECO:0000269|PubMed:11461922,
CC       ECO:0000269|PubMed:17407445, ECO:0000269|PubMed:17900240}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.08 mM for L-ornithine {ECO:0000269|PubMed:17407445};
CC         Note=kcat is 3.3 sec(-1) with L-ornithine as substrate.
CC         {ECO:0000269|PubMed:17407445};
CC   -!- PATHWAY: Amine and polyamine biosynthesis; putrescine biosynthesis
CC       via L-ornithine pathway; putrescine from L-ornithine: step 1/1.
CC   -!- SUBUNIT: Homodimer. Only the dimer is catalytically active, as the
CC       active sites are constructed of residues from both monomers
CC       (Probable). Does not form a heterodimer with AZIN2 (By
CC       similarity). {ECO:0000250|UniProtKB:P00860,
CC       ECO:0000305|PubMed:10623504}.
CC   -!- INTERACTION:
CC       Q9H8Y8:GORASP2; NbExp=9; IntAct=EBI-1044287, EBI-739467;
CC       Q92993:KAT5; NbExp=5; IntAct=EBI-1044287, EBI-399080;
CC       Q9UMX2:OAZ3; NbExp=3; IntAct=EBI-1044287, EBI-10281601;
CC       Q9UMX2-2:OAZ3; NbExp=4; IntAct=EBI-1044287, EBI-12049527;
CC   -!- INDUCTION: Down-regulated in response to enterovirus 71 (EV71)
CC       infection (at protein level). {ECO:0000269|PubMed:16548883}.
CC   -!- PTM: S-Nitrosylation inhibits the enzyme. S-Nitrosylated in vitro
CC       on 4 cysteine residues. {ECO:0000269|PubMed:10462479,
CC       ECO:0000269|PubMed:11461922}.
CC   -!- SIMILARITY: Belongs to the Orn/Lys/Arg decarboxylase class-II
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/odc1/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ornithine decarboxylase entry;
CC       URL="https://en.wikipedia.org/wiki/Ornithine_decarboxylase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16650; AAA59966.2; -; mRNA.
DR   EMBL; M31061; AAA60563.1; -; Genomic_DNA.
DR   EMBL; X16277; CAA34353.1; -; Genomic_DNA.
DR   EMBL; M33764; AAA60564.1; -; Genomic_DNA.
DR   EMBL; M34158; AAA59969.1; -; Genomic_DNA.
DR   EMBL; M81740; AAA59967.1; -; Genomic_DNA.
DR   EMBL; X55362; CAA39047.1; -; mRNA.
DR   EMBL; AK292352; BAF85041.1; -; mRNA.
DR   EMBL; AK312766; BAG35632.1; -; mRNA.
DR   EMBL; AY841870; AAV88093.1; -; Genomic_DNA.
DR   EMBL; AC007249; AAY15034.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00958.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00959.1; -; Genomic_DNA.
DR   EMBL; BC025296; AAH25296.1; -; mRNA.
DR   EMBL; X53271; CAA37369.1; -; mRNA.
DR   EMBL; M20372; AAA59968.1; -; mRNA.
DR   CCDS; CCDS1672.1; -.
DR   PIR; S06900; DCHUO.
DR   RefSeq; NP_001274118.1; NM_001287189.1.
DR   RefSeq; NP_001274119.1; NM_001287190.1.
DR   RefSeq; NP_002530.1; NM_002539.2.
DR   UniGene; Hs.467701; -.
DR   PDB; 1D7K; X-ray; 2.10 A; A/B=7-427.
DR   PDB; 2ON3; X-ray; 3.00 A; A/B=1-461.
DR   PDB; 2OO0; X-ray; 1.90 A; A/B=1-461.
DR   PDB; 4ZGY; X-ray; 2.63 A; A=2-421.
DR   PDB; 5BWA; X-ray; 3.20 A; A=1-461.
DR   PDBsum; 1D7K; -.
DR   PDBsum; 2ON3; -.
DR   PDBsum; 2OO0; -.
DR   PDBsum; 4ZGY; -.
DR   PDBsum; 5BWA; -.
DR   ProteinModelPortal; P11926; -.
DR   SMR; P11926; -.
DR   BioGrid; 111007; 9.
DR   IntAct; P11926; 16.
DR   MINT; MINT-1208473; -.
DR   STRING; 9606.ENSP00000234111; -.
DR   BindingDB; P11926; -.
DR   ChEMBL; CHEMBL1869; -.
DR   DrugBank; DB03856; Alpha-Difluoromethylornithine.
DR   DrugBank; DB06243; Eflornithine.
DR   DrugBank; DB04263; Geneticin.
DR   DrugBank; DB04083; N'-Pyridoxyl-Lysine-5'-Monophosphate.
DR   DrugBank; DB02824; N-Pyridoxyl-Glycine-5-Monophosphate.
DR   DrugBank; DB01917; Putrescine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB02209; Pyridoxine-5'-Phosphate.
DR   DrugBank; DB00127; Spermine.
DR   GuidetoPHARMACOLOGY; 1276; -.
DR   iPTMnet; P11926; -.
DR   PhosphoSitePlus; P11926; -.
DR   BioMuta; ODC1; -.
DR   DMDM; 118377; -.
DR   EPD; P11926; -.
DR   PaxDb; P11926; -.
DR   PeptideAtlas; P11926; -.
DR   PRIDE; P11926; -.
DR   DNASU; 4953; -.
DR   Ensembl; ENST00000234111; ENSP00000234111; ENSG00000115758.
DR   Ensembl; ENST00000405333; ENSP00000385333; ENSG00000115758.
DR   GeneID; 4953; -.
DR   KEGG; hsa:4953; -.
DR   UCSC; uc002rao.3; human.
DR   CTD; 4953; -.
DR   DisGeNET; 4953; -.
DR   GeneCards; ODC1; -.
DR   HGNC; HGNC:8109; ODC1.
DR   HPA; CAB035996; -.
DR   HPA; HPA001536; -.
DR   MalaCards; ODC1; -.
DR   MIM; 165640; gene.
DR   neXtProt; NX_P11926; -.
DR   OpenTargets; ENSG00000115758; -.
DR   PharmGKB; PA31897; -.
DR   eggNOG; KOG0622; Eukaryota.
DR   eggNOG; COG0019; LUCA.
DR   GeneTree; ENSGT00390000011560; -.
DR   HOGENOM; HOG000274133; -.
DR   HOVERGEN; HBG005456; -.
DR   InParanoid; P11926; -.
DR   KO; K01581; -.
DR   OMA; PACCGRE; -.
DR   OrthoDB; EOG091G0AJV; -.
DR   PhylomeDB; P11926; -.
DR   TreeFam; TF300760; -.
DR   BioCyc; MetaCyc:HS03935-MONOMER; -.
DR   BRENDA; 4.1.1.17; 2681.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-351202; Metabolism of polyamines.
DR   SABIO-RK; P11926; -.
DR   UniPathway; UPA00535; UER00288.
DR   ChiTaRS; ODC1; human.
DR   EvolutionaryTrace; P11926; -.
DR   GeneWiki; ODC1; -.
DR   GenomeRNAi; 4953; -.
DR   PRO; PR:P11926; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115758; -.
DR   CleanEx; HS_ODC1; -.
DR   ExpressionAtlas; P11926; baseline and differential.
DR   Genevisible; P11926; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0004586; F:ornithine decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0006595; P:polyamine metabolic process; TAS:Reactome.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0033387; P:putrescine biosynthetic process from ornithine; ISS:UniProtKB.
DR   GO; GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome.
DR   GO; GO:0042176; P:regulation of protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   Gene3D; 2.40.37.10; -; 2.
DR   Gene3D; 3.20.20.10; -; 1.
DR   InterPro; IPR009006; Ala_racemase/Decarboxylase_C.
DR   InterPro; IPR022643; De-COase2_C.
DR   InterPro; IPR022657; De-COase2_CS.
DR   InterPro; IPR022644; De-COase2_N.
DR   InterPro; IPR022653; De-COase2_pyr-phos_BS.
DR   InterPro; IPR000183; Orn/DAP/Arg_de-COase.
DR   InterPro; IPR002433; Orn_de-COase.
DR   InterPro; IPR029066; PLP-binding_barrel.
DR   Pfam; PF02784; Orn_Arg_deC_N; 1.
DR   Pfam; PF00278; Orn_DAP_Arg_deC; 1.
DR   PRINTS; PR01179; ODADCRBXLASE.
DR   PRINTS; PR01182; ORNDCRBXLASE.
DR   SUPFAM; SSF50621; SSF50621; 1.
DR   SUPFAM; SSF51419; SSF51419; 1.
DR   PROSITE; PS00878; ODR_DC_2_1; 1.
DR   PROSITE; PS00879; ODR_DC_2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Decarboxylase; Lyase; Phosphoprotein;
KW   Polyamine biosynthesis; Pyridoxal phosphate; Reference proteome;
KW   S-nitrosylation.
FT   CHAIN         1    461       Ornithine decarboxylase.
FT                                /FTId=PRO_0000149891.
FT   REGION      274    277       Pyridoxal phosphate binding.
FT                                {ECO:0000244|PDB:2OO0,
FT                                ECO:0000269|PubMed:17407445,
FT                                ECO:0000269|PubMed:26305948,
FT                                ECO:0000269|PubMed:26443277}.
FT   REGION      331    332       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P07805}.
FT   ACT_SITE    360    360       Proton donor; shared with dimeric
FT                                partner. {ECO:0000305|PubMed:10623504}.
FT   BINDING     200    200       Pyridoxal phosphate.
FT                                {ECO:0000244|PDB:2OO0,
FT                                ECO:0000269|PubMed:17407445}.
FT   BINDING     237    237       Pyridoxal phosphate; via amino nitrogen.
FT                                {ECO:0000244|PDB:2OO0,
FT                                ECO:0000269|PubMed:17407445}.
FT   BINDING     361    361       Substrate; shared with dimeric partner.
FT                                {ECO:0000250|UniProtKB:P07805}.
FT   BINDING     389    389       Pyridoxal phosphate.
FT                                {ECO:0000244|PDB:2OO0,
FT                                ECO:0000269|PubMed:17407445,
FT                                ECO:0000269|PubMed:26305948,
FT                                ECO:0000269|PubMed:26443277}.
FT   SITE        197    197       Stacks against the aromatic ring of
FT                                pyridoxal phosphate and stabilizes
FT                                reaction intermediates.
FT                                {ECO:0000250|UniProtKB:P00860}.
FT   MOD_RES      69     69       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000269|PubMed:26305948,
FT                                ECO:0000305|PubMed:17407445}.
FT   MOD_RES     303    303       Phosphoserine; by CK2. {ECO:0000250}.
FT   MOD_RES     360    360       S-nitrosocysteine; in inhibited form.
FT                                {ECO:0000305|PubMed:11461922}.
FT   MUTAGEN     360    360       C->A: 25% decrease of in vitro
FT                                nitrosylation level.
FT                                {ECO:0000269|PubMed:11461922}.
FT   HELIX         1      5       {ECO:0000244|PDB:2OO0}.
FT   TURN          6      8       {ECO:0000244|PDB:2OO0}.
FT   STRAND       11     14       {ECO:0000244|PDB:2OO0}.
FT   HELIX        20     30       {ECO:0000244|PDB:2OO0}.
FT   TURN         31     33       {ECO:0000244|PDB:2OO0}.
FT   STRAND       40     44       {ECO:0000244|PDB:2OO0}.
FT   HELIX        45     58       {ECO:0000244|PDB:2OO0}.
FT   STRAND       62     67       {ECO:0000244|PDB:2OO0}.
FT   HELIX        68     70       {ECO:0000244|PDB:2OO0}.
FT   HELIX        74     83       {ECO:0000244|PDB:2OO0}.
FT   STRAND       86     89       {ECO:0000244|PDB:2OO0}.
FT   HELIX        92    100       {ECO:0000244|PDB:2OO0}.
FT   HELIX       105    107       {ECO:0000244|PDB:2OO0}.
FT   STRAND      108    110       {ECO:0000244|PDB:2OO0}.
FT   HELIX       117    125       {ECO:0000244|PDB:2OO0}.
FT   STRAND      130    133       {ECO:0000244|PDB:2OO0}.
FT   HELIX       136    145       {ECO:0000244|PDB:2OO0}.
FT   STRAND      150    155       {ECO:0000244|PDB:2OO0}.
FT   STRAND      162    164       {ECO:0000244|PDB:2OO0}.
FT   TURN        167    169       {ECO:0000244|PDB:2OO0}.
FT   HELIX       174    186       {ECO:0000244|PDB:2OO0}.
FT   STRAND      190    195       {ECO:0000244|PDB:2OO0}.
FT   HELIX       206    225       {ECO:0000244|PDB:2OO0}.
FT   STRAND      231    233       {ECO:0000244|PDB:2OO0}.
FT   STRAND      240    246       {ECO:0000244|PDB:2OO0}.
FT   HELIX       248    262       {ECO:0000244|PDB:2OO0}.
FT   HELIX       265    267       {ECO:0000244|PDB:2OO0}.
FT   STRAND      270    273       {ECO:0000244|PDB:2OO0}.
FT   HELIX       277    280       {ECO:0000244|PDB:2OO0}.
FT   HELIX       281    283       {ECO:0000244|PDB:2OO0}.
FT   STRAND      284    296       {ECO:0000244|PDB:2OO0}.
FT   STRAND      313    319       {ECO:0000244|PDB:2OO0}.
FT   TURN        322    324       {ECO:0000244|PDB:2OO0}.
FT   HELIX       325    327       {ECO:0000244|PDB:2OO0}.
FT   HELIX       328    331       {ECO:0000244|PDB:2OO0}.
FT   STRAND      339    342       {ECO:0000244|PDB:2OO0}.
FT   STRAND      350    356       {ECO:0000244|PDB:2OO0}.
FT   STRAND      358    360       {ECO:0000244|PDB:2OO0}.
FT   STRAND      365    373       {ECO:0000244|PDB:2OO0}.
FT   STRAND      380    383       {ECO:0000244|PDB:2OO0}.
FT   STRAND      388    390       {ECO:0000244|PDB:2OO0}.
FT   HELIX       391    393       {ECO:0000244|PDB:2OO0}.
FT   HELIX       397    399       {ECO:0000244|PDB:2OO0}.
FT   STRAND      404    410       {ECO:0000244|PDB:2OO0}.
FT   HELIX       411    420       {ECO:0000244|PDB:2OO0}.
SQ   SEQUENCE   461 AA;  51148 MW;  8CCB88CE80E823C5 CRC64;
     MNNFGNEEFD CHFLDEGFTA KDILDQKINE VSSSDDKDAF YVADLGDILK KHLRWLKALP
     RVTPFYAVKC NDSKAIVKTL AATGTGFDCA SKTEIQLVQS LGVPPERIIY ANPCKQVSQI
     KYAANNGVQM MTFDSEVELM KVARAHPKAK LVLRIATDDS KAVCRLSVKF GATLRTSRLL
     LERAKELNID VVGVSFHVGS GCTDPETFVQ AISDARCVFD MGAEVGFSMY LLDIGGGFPG
     SEDVKLKFEE ITGVINPALD KYFPSDSGVR IIAEPGRYYV ASAFTLAVNI IAKKIVLKEQ
     TGSDDEDESS EQTFMYYVND GVYGSFNCIL YDHAHVKPLL QKRPKPDEKY YSSSIWGPTC
     DGLDRIVERC DLPEMHVGDW MLFENMGAYT VAAASTFNGF QRPTIYYVMS GPAWQLMQQF
     QNPDFPPEVE EQDASTLPVS CAWESGMKRH RAACASASIN V
//
